Skip to main content

biopharma-drugs-rgb

The recent bumpy landing of Philae on comet 67P/Churyumov-Gerasimenko after a ten year journey, and more than 1.4 billion euros in investment, is a fantastic example of European science, expertise and collaboration at work.

{iframe}http://www.euractiv.com/sections/health-consumers/new-debate-needed-biopharmaceuticals-310550{/iframe}
Close Menu

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.